Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06585917

Comparison of 6F and 7F Sheaths for Coronary Intervention Via Distal Radial Artery Access

This is a multicenter, randomized controlled, prospective, non-inferiority, open-label study aiming to evaluate whether the efficacy and safety of using a 7F thin-walled sheath via distal radial artery (dTRA) access for coronary intervention (PCI) are non-inferior to the use of a 6F thin-walled sheath. The study population includes adult patients who are candidates for coronary intervention. The primary endpoint is the rate of radial artery and distal radial artery occlusion 24 hours post-procedure.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fuwai Hospital, CAMS & PUMC

Beijing, Beijing Municipality, 100037, China

About this study

This study is a multicenter, randomized controlled, prospective, non-inferiority, open-label clinical trial designed to compare the efficacy and safety of using 7F thin-walled sheaths versus 6F thin-walled sheaths for coronary intervention (PCI) via distal radial artery access (dTRA). The study will enroll adult patients with coronary artery disease who are scheduled to undergo PCI.

Participants will be randomized into two groups: the experimental group, which will receive PCI using a 7F sheath, and the control group, which will receive PCI using a 6F sheath. The primary endpoint is the rate of radial artery and distal radial artery occlusion 24 hours post-procedure, assessed by ultrasound. Secondary endpoints include the incidence of major adverse cardiovascular and cerebrovascular events during follow-up, cannulation success rate, PCI success rate, and the rate of radial artery occlusion at 30 days post-procedure, among others.

The study aims to determine whether the 7F sheath is non-inferior to the 6F sheath in terms of safety and efficacy for PCI through dTRA. The study will be conducted at multiple centers in China, with a planned enrollment of 574 participants, and it will span from Sep 2024 to January 2026. All procedures will adhere to the highest standards of clinical practice, and patient data will be managed with strict confidentiality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years and ≤80 years;
  • Height ≤180 cm;
  • Distal radial artery diameter ≥1.7 mm;
  • Completed distal radial artery angiography and requires coronary intervention;
  • Tolerates dual antiplatelet therapy and intraoperative anticoagulant therapy, with no history of related drug allergies;
  • Patient consents to participate in the study.

Exclusion criteria

  • Acute myocardial infarction requiring emergency PCI;
  • Ultrasound-confirmed occlusion of the radial artery on the procedure side;
  • Radial artery and distal radial artery anomalies (e.g., small caliber, tortuous, looped vessels) that make the dTRA approach unsuitable;
  • Previous bilateral radial artery intervention or surgery;
  • No coronary intervention performed after coronary angiography;
  • Inability to undergo coronary angiography and intervention due to subjective or objective reasons;
  • Coronary lesions requiring the use of a 7F guiding catheter;
  • Coronary arteries not suitable for 7F guiding catheter;
  • Severe liver or renal insufficiency, unresolved bleeding disorders, or other serious conditions with an expected survival of less than 1 year;
  • Currently breastfeeding or known pregnancy.

Treatment and study plan

7F Thin-Walled Sheath

Device

The 7F Thin-Walled Sheath is used during coronary intervention procedures via distal radial artery access. This device has a smaller outer diameter compared to traditional 7F sheaths, designed to reduce the risk of vascular complications while allowing for the performance of complex coronary interventions.

6F Thin-Walled Sheath

Device

The 6F Thin-Walled Sheath is the standard device used in coronary intervention procedures via distal radial artery access. It is employed as a control in this study to compare its efficacy and safety against the 7F Thin-Walled Sheath.

Primary outcomes

  1. Radial Artery Occlusion Rate 24 Hours Post-Procedure

    Time frame: 24 hours post-procedure

    The primary outcome is the rate of radial artery and distal radial artery occlusion 24 hours after the procedure. Occlusion will be determined by the absence of blood flow spectrum in the radial artery as assessed by ultrasound.

Secondary outcomes

  1. Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

    Time frame: Up to 30 days post-procedure

    The incidence of major adverse cardiovascular and cerebrovascular events during the follow-up period, including all-cause mortality, cardiovascular mortality, new-onset myocardial infarction, and new-onset stroke.

  2. Cannulation Success Rate

    Time frame: During the procedure

    The success rate of sheath insertion and placement in the radial artery during the coronary intervention procedure.

  3. PCI Success Rate

    Time frame: During the procedure

    The success rate of the percutaneous coronary intervention (PCI) procedure, defined by the successful completion of the intended intervention with appropriate device placement and without the need for conversion to an alternative access site.

  4. Radial Artery Occlusion Rate 30 Days Post-Procedure

    Time frame: 30 days post-procedure

    The rate of radial artery and distal radial artery occlusion 30 days after the procedure, assessed by ultrasound.

  5. Major Bleeding Events

    Time frame: Up to 30 days post-procedure

    The incidence of major bleeding events, defined according to the Bleeding Academic Research Consortium (BARC) criteria (Type 3 or Type 5 bleeding).

  6. Local Neurological Complications

    Time frame: Up to 30 days post-procedure

    The incidence of local neurological complications, including numbness, tingling, or motor deficits in the arm used for radial artery access.

  7. Incidence and Severity of Forearm Hematoma

    Time frame: Up to 30 days post-procedure

    Forearm hematoma will be graded using the EASY (Early Discharge After Transradial Stenting of Coronary Arteries Study) hematoma scale. The scale ranges from Grade I to Grade V:

    Grade I: Hematoma <5 cm in diameter (non-significant) Grade II: Hematoma 5-10 cm in diameter (mild) Grade III: Hematoma >10 cm but distal to the elbow (moderate) Grade IV: Hematoma extending above the elbow (severe) Grade V: Hematoma associated with ischemic threat to the hand (compartment syndrome) Higher grades indicate worse outcomes.

  8. Pain Scores

    Time frame: Up to 30 days post-procedure

    Patient-reported pain scores assessed using the Visual Analog Scale (VAS). The scale ranges from 0 (no pain) to 10 (worst pain), with higher scores indicating worse outcomes.

  9. Daily Living Ability Scores

    Time frame: Up to 30 days post-procedure

    Daily living abilities assessed using the Barthel Index, which ranges from 0 (complete dependence) to 100 (complete independence), with higher scores indicating better outcomes.

  10. Length of Hospital Stay

    Time frame: From the time of admission for the procedure until the date of discharge, assessed up to 30 days post-procedure

    The total length of hospital stay, measured in days, starting from the date of admission for the coronary intervention procedure until the date of discharge, with a maximum assessment period of up to 30 days post-procedure.

  11. Unplanned Additional Interventions During Hospitalization

    Time frame: From the time of procedure until discharge, assessed up to 30 days post-procedure

    The incidence of unplanned additional interventions required during the initial hospitalization, including but not limited to additional PCI, vascular repair, or treatment of complications. The events will be assessed from the time of the procedure until the patient is discharged, with a maximum assessment period of up to 30 days post-procedure.

Sponsors and collaborators

Lead sponsor

China National Center for Cardiovascular Diseases

Other Gov

Registry information

Official study title

A Multicenter Study Comparing the Efficacy and Safety of 6F and 7F Thin-Walled Sheaths Via Distal Radial Artery Access for Coronary Intervention

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Sep 19, 2024
Registry last updated
Feb 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.